US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Belite Bio, Inc | $146.12 | -1.5% | $5.86B | -63.3 | -78.4% | — | Healthcare | 142.1% | — | ||
| 2 | Opus Genetics, Inc. | $4.07 | 0.2% | $3.54B | -5.1 | 32.5% | — | Healthcare | 337% | -12.2% | ||
| 3 | Tarsus Pharmaceuticals, Inc. | $63.16 | 1% | $2.72B | -39.7 | 58.2% | — | Healthcare | 53.8% | 129% | ||
| 4 | Ocular Therapeutix, Inc. | $9.43 | -2.2% | $2.06B | -6.6 | -27% | — | Healthcare | 13.2% | -12.8% | ||
| 5 | Kodiak Sciences Inc. | $36.14 | 1.2% | $1.91B | -8.4 | -14.9% | — | Healthcare | 923.8% | — | ||
| 6 | Viridian Therapeutics, Inc. | $16.63 | -0.5% | $1.41B | -5.0 | 9.6% | — | Healthcare | 10.9% | 23382.8% | ||
| 7 | EyePoint Pharmaceuticals, Inc. | $13.58 | 3.3% | $1.14B | -4.3 | -45.2% | — | Healthcare | 52.2% | -86.4% | ||
| 8 | Oculis Holding AG | $11.22 | -0.7% | $641M | -5.0 | 27% | — | Healthcare | -42.4% | — | ||
| 9 | LENZ Therapeutics, Inc. | $6.15 | -3% | $193M | -2.2 | -103.4% | — | Healthcare | -79.5% | — | ||
| 10 | Aldeyra Therapeutics, Inc. | $1.96 | 7.1% | $118M | -3.5 | 52.9% | — | Healthcare | -38.2% | — | ||
| 11 | KALA BIO, Inc. | $3.61 | 26.9% | $79M | -1.1 | 64.9% | — | Healthcare | -98.3% | — | ||
| 12 | Outlook Therapeutics, Inc. | $1.58 | -4.2% | $65M | -0.9 | -10.6% | — | Healthcare | -6% | 95.8% | ||
| 13 | OKYO Pharma Limited | $1.59 | 1.3% | $61M | -13.3 | 47.6% | — | Healthcare | -29.3% | — | ||
| 14 | Skye Bioscience, Inc. | $0.71 | -0.6% | $25M | -0.5 | -75.6% | — | Healthcare | -66.9% | — | ||
| 15 | Kiora Pharmaceuticals, Inc. | $2.53 | -1.6% | $11M | -1.0 | 17.3% | — | Healthcare | -16.2% | — | ||
| 16 | NovaBay Pharmaceuticals, Inc. | $1.47 | -21.8% | $9M | -0.6 | 101.1% | — | Healthcare | -51.8% | -74.7% | ||
| 17 | Clearside Biomedical, Inc. | $0.41 | 0% | $2M | -0.1 | 23.9% | — | Healthcare | -96.5% | -56.8% |
Showing 17 stocks